Trimetazidina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trimetazidina" in Italian language version.

refsWebsite

Global rank Italian rank

7nih.gov

4^th place

9^th place

5doi.org

2^nd place

7^th place

2agenziafarmaco.gov.it

low place

1,603^rd place

1cts-mrp.eu

low place

1europa.eu

68^th place

57^th place

1caymanchem.com

low place

agenziafarmaco.gov.it

farmaci.agenziafarmaco.gov.it

AIFA Foglio illustrativo: informazioni per il paziente VASTAREL 20 mg compresse rivestite con film trimetazidina dicloridrato, su farmaci.agenziafarmaco.gov.it.
AIFA - RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO, su farmaci.agenziafarmaco.gov.it.

caymanchem.com

cdn.caymanchem.com

Cayman Chemical: Trimetazidine MSDS - Safety Data Sheet. Acc. to OSHA HCS (PDF), su cdn.caymanchem.com.

cts-mrp.eu

mri.cts-mrp.eu

Icelandic Medicines Agency: Trimetazidine Oral Modified Release Tablets (Summary of Product Characteristics) ^{[collegamento interrotto]}, su mri.cts-mrp.eu.

doi.org

dx.doi.org

Alan MacInnes, David A. Fairman e Peter Binding, The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase, in Circulation Research, vol. 93, n. 3, 8 agosto 2003, pp. e26–32, DOI:10.1161/01.RES.0000086943.72932.71. URL consultato il 26 giugno 2023.
P. F. Kantor, A. Lucien e R. Kozak, The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase, in Circulation Research, vol. 86, n. 5, 17 marzo 2000, pp. 580–588, DOI:10.1161/01.res.86.5.580. URL consultato il 26 giugno 2023.
J. Barré, P. Ledudal e B. Oosterhuis, Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure, in Biopharmaceutics & Drug Disposition, vol. 24, n. 4, 2003-05, pp. 159–164, DOI:10.1002/bdd.350. URL consultato il 26 giugno 2023.
Shuangjiao Sun, Chanjuan Long e Chunyao Tao, Ultrasonic microdialysis coupled with capillary electrophoresis electrochemiluminescence study the interaction between trimetazidine dihydrochloride and human serum albumin, in Analytica Chimica Acta, vol. 851, 3 dicembre 2014, pp. 37–42, DOI:10.1016/j.aca.2014.08.012. URL consultato il 26 giugno 2023.
P. J. Jackson, R. D. Brownsill e A. R. Taylor, Identification of trimetazidine metabolites in human urine and plasma, in Xenobiotica; the Fate of Foreign Compounds in Biological Systems, vol. 26, n. 2, 1996-02, pp. 221–228, DOI:10.3109/00498259609046702. URL consultato il 26 giugno 2023.

europa.eu

ema.europa.eu

EMA Assessment Report: Trimetazidine Containing Medicinal Products - Assessment Report for trimetazidine containing medicinal products. 3 September 2012 EMA/CHMP/584736/2012 (PDF), su ema.europa.eu.

nih.gov

pubmed.ncbi.nlm.nih.gov

T. N. Mehrotra e E. T. Bassadone, Trimetazidine in the treatment of angina pectoris, in The British Journal of Clinical Practice, vol. 21, n. 11, 11 novembre 1967, pp. 553–554. URL consultato il 26 giugno 2023.
P. Brodbin e C. A. O'Connor, Trimetazidine in the treatment of angina pectoris, in The British Journal of Clinical Practice, vol. 22, n. 9, 1968-09, pp. 395–396. URL consultato il 26 giugno 2023.
Alan MacInnes, David A. Fairman e Peter Binding, The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase, in Circulation Research, vol. 93, n. 3, 8 agosto 2003, pp. e26–32, DOI:10.1161/01.RES.0000086943.72932.71. URL consultato il 26 giugno 2023.
P. F. Kantor, A. Lucien e R. Kozak, The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase, in Circulation Research, vol. 86, n. 5, 17 marzo 2000, pp. 580–588, DOI:10.1161/01.res.86.5.580. URL consultato il 26 giugno 2023.
J. Barré, P. Ledudal e B. Oosterhuis, Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure, in Biopharmaceutics & Drug Disposition, vol. 24, n. 4, 2003-05, pp. 159–164, DOI:10.1002/bdd.350. URL consultato il 26 giugno 2023.
Shuangjiao Sun, Chanjuan Long e Chunyao Tao, Ultrasonic microdialysis coupled with capillary electrophoresis electrochemiluminescence study the interaction between trimetazidine dihydrochloride and human serum albumin, in Analytica Chimica Acta, vol. 851, 3 dicembre 2014, pp. 37–42, DOI:10.1016/j.aca.2014.08.012. URL consultato il 26 giugno 2023.
P. J. Jackson, R. D. Brownsill e A. R. Taylor, Identification of trimetazidine metabolites in human urine and plasma, in Xenobiotica; the Fate of Foreign Compounds in Biological Systems, vol. 26, n. 2, 1996-02, pp. 221–228, DOI:10.3109/00498259609046702. URL consultato il 26 giugno 2023.